Logo image of AKRX

Akorn Inc (AKRX) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:AKRX -

0.09
-0.09 (-51.01%)
Last: 5/29/2020, 8:01:22 PM
0.1299
+0.04 (+44.33%)
After Hours: 5/29/2020, 8:01:22 PM

AKRX Key Statistics, Chart & Performance

Key Statistics
Market Cap11.98M
Revenue(TTM)721.25M
Net Income(TTM)-401.32M
Shares133.15M
Float96.26M
52 Week High5.46
52 Week Low0.09
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)0.14
PE0.64
Fwd PEN/A
Earnings (Next)N/A N/A
IPON/A
Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A


AKRX short term performance overview.The bars show the price performance of AKRX in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60 -80

AKRX long term performance overview.The bars show the price performance of AKRX in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of AKRX is 0.09 null. In the past month the price decreased by -57.14%. In the past year, price decreased by -97.82%.

Akorn Inc / AKRX Daily stock chart

AKRX Latest News, Press Relases and Analysis

About AKRX

Company Profile

Akorn, Inc. is a specialty generic pharmaceutical company engaged in the development, manufacture and marketing of multisource and branded pharmaceuticals. They specialize in difficult-to-manufacture sterile and non-sterile dosage forms including: ophthalmics, injectables, oral liquids, otics, topicals, inhalants, and nasal sprays. Akorn markets its products to retail pharmacies, ophthalmologists, optometrists, physicians, veterinarians, hospitals, clinics, wholesalers, distributors, group purchasing organizations, and government agencies. Their strategy is focused on continuing to strengthen our leadership position in the development and marketing of specialized generic and branded pharmaceuticals, over-the-counter (`OTC`) drug products and animal health products.

Company Info

Akorn Inc

1925 WEST FIELD COURT SUITE 300

LAKE FOREST IL 60045

CEO: Douglas S. Boothe

Phone: 847-279-6100

Akorn Inc / AKRX FAQ

Can you describe the business of Akorn Inc?

Akorn, Inc. is a specialty generic pharmaceutical company engaged in the development, manufacture and marketing of multisource and branded pharmaceuticals. They specialize in difficult-to-manufacture sterile and non-sterile dosage forms including: ophthalmics, injectables, oral liquids, otics, topicals, inhalants, and nasal sprays. Akorn markets its products to retail pharmacies, ophthalmologists, optometrists, physicians, veterinarians, hospitals, clinics, wholesalers, distributors, group purchasing organizations, and government agencies. Their strategy is focused on continuing to strengthen our leadership position in the development and marketing of specialized generic and branded pharmaceuticals, over-the-counter (`OTC`) drug products and animal health products.


What is the stock price of Akorn Inc today?

The current stock price of AKRX is 0.09 null. The price decreased by -51.01% in the last trading session.


What is the dividend status of Akorn Inc?

AKRX does not pay a dividend.


How is the ChartMill rating for Akorn Inc?

AKRX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 4 out of 10.


What is Akorn Inc worth?

Akorn Inc (AKRX) has a market capitalization of 11.98M null. This makes AKRX a Nano Cap stock.


AKRX Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

AKRX Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to AKRX. While AKRX is still in line with the averages on profitability rating, there are concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

AKRX Financial Highlights

Over the last trailing twelve months AKRX reported a non-GAAP Earnings per Share(EPS) of 0.14000000000000004. The EPS increased by 122.58% compared to the year before.


Industry RankSector Rank
PM (TTM) -55.64%
ROA -38.88%
ROE N/A
Debt/Equity -1.1
Chartmill High Growth Momentum
EPS Q2Q%342.86%
Sales Q2Q%23.4%
EPS 1Y (TTM)122.58%
Revenue 1Y (TTM)6.72%

AKRX Forecast & Estimates


Analysts
Analysts60
Price TargetN/A
EPS Next Y-2.94%
Revenue Next YearN/A

AKRX Ownership

Ownership
Inst Owners0%
Ins Owners2.7%
Short Float %N/A
Short RatioN/A